A Randomized Clinical Hypnosis Pilot Study: Improvements in Self-Reported Pain Impact in Adults with Sickle Cell Disease

Figure 1

Hypnosis pilot: experimental versus control intervention with SCD patients. Of the 15 participants in Group A (hypnosis arm), 10 participants were considered completers and their data was used in the final analysis. Three participants withdrew (after weeks 0, 1, and 8) and two participants were lost to follow-up (one after week 0 and another after week 5). Of the 16 participants in Group B (control arm), seven completed the study. Six participants withdrew from the study at different time points (weeks 1, 4, 12, 14, and 22), whereas three were lost to follow-up: after week 5, week 14, and week 15.